Gabify Raises $175K Pre-seed Round Led By Inflection Point Ventures

Gabify has raised USD 175,000 in a pre-seed funding round led by Inflection Point Ventures (IPV), as it looks to scale its AI-powered platform for early screening and therapy management of neurodevelopmental disorders.

The startup has also secured Rs 25 lakh under the Nidhi Seed Support Scheme from GH Raisoni Technology Business Incubator Foundation, a government-backed initiative supporting early-stage innovation.

The fresh capital will be utilised across clinical validation, technology enhancement, and team expansion, aimed at accelerating growth and building a sustainable revenue model.

Founded to address gaps in early diagnosis, Gabify offers an end-to-end AI-driven SaaS ecosystem for speech and neurodevelopmental conditions, including Autism and ADHD. Its platform leverages dual AI—voice and vision—to analyse speech patterns, facial expressions, and behavioural indicators based on over 189 clinically validated parameters aligned with DSM-5 and CARS frameworks.

The system incorporates a human-in-the-loop (HITL) approach, enabling clinicians to validate AI outputs, ensuring accuracy and professional oversight. Designed for scalability, the platform is multilingual, low-bandwidth compatible, and suited for rural deployment.

Gabify has been part of IPV’s IdeaSchool incubator programme and has tested its solutions across more than 35 preschool and daycare centres in India. Its platform is already being adopted by schools, hospitals, NGOs, and private practitioners.

The startup has also gained recognition as one of the Top 10 startups under DreamDeal, an initiative led by Anupam Mittal, and has received multiple accolades across national and global platforms, including participation in UNDP Youth Co:Lab.

Looking ahead, Gabify aims to impact one million children by 2028 through a mix of B2B, B2C, and CSR-led deployments, as demand rises for accessible, AI-led healthcare solutions in early intervention.